Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Clin Nutr ; 89(5): 1393-401, 2009 May.
Article in English | MEDLINE | ID: mdl-19357220

ABSTRACT

BACKGROUND: Recent reports suggest that the metabolic activity of the gut microbiota may contribute to the pathogenesis of obesity and hepatic steatosis. OBJECTIVE: The objective was to determine whether the fat composition of host tissues might be influenced by oral administration of commensal bifidobacteria previously shown by us to produce bioactive isomers of conjugated linoleic acid (CLA). DESIGN: Murine trials were conducted in which linoleic acid-supplemented diets were fed with or without Bifidobacterium breve NCIMB 702258 (daily dose of 10(9) microorganisms) to healthy BALB/c mice and to severe combined immunodeficient mice for 8-10 wk. To ensure that the observations were not peculiar to mice, a similar trial was conducted in weanling pigs over 21 d. Tissue fatty acid composition was assessed by gas-liquid chromatography. RESULTS: In comparison with controls, there was an increase in cis-9, trans-11 CLA in the livers of the mice and pigs after feeding with linoleic acid in combination with B. breve NCIMB 702258 (P < 0.05). In addition, an altered profile of polyunsaturated fatty acid composition was observed, including higher concentrations of the omega-3 (n-3) fatty acids eicosapentaenoic acid and docosahexaenoic acid in adipose tissue (P < 0.05). These changes were associated with reductions in the proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma (P < 0.05). CONCLUSIONS: These results are consistent with the concept that the metabolome is a composite of host and microbe metabolic activity and that the influence of the microbiota on host fatty acid composition can be manipulated by oral administration of CLA-producing microorganisms.


Subject(s)
Adipose Tissue/metabolism , Adipose Tissue/microbiology , Bifidobacterium/metabolism , Fatty Acids/metabolism , Liver/metabolism , Liver/microbiology , Animal Feed , Animals , Feces/microbiology , Lymphocytes/immunology , Lymphocytes/microbiology , Male , Mice , Mice, Inbred BALB C , Swine
2.
FEMS Microbiol Ecol ; 64(2): 317-27, 2008 May.
Article in English | MEDLINE | ID: mdl-18373687

ABSTRACT

Relative predominance of each of five probiotic strains was investigated in the ileum of weaned pigs, compared with that in feces, when administered in combination at c. 5 x 10(9) CFU day(-1) for 28 days. Probiotic was excreted at 10(6)-10(9) CFU g(-1) feces, while ileal survival ranged from 10(2) to 10(6) CFU g(-1) digesta. In contrast to the feces, where Lactobacillus murinus DPC6002 predominated, the bacteriocin-producing Lactobacillus salivarus DPC6005 dominated over coadministered strains both in the ileum digesta and in mucosa. Probiotic administration did not alter counts of culturable fecal Lactobacillus or Enterobacteriaceae but higher ileal Enterobacteriaceae were observed in the ileal digesta of probiotic-fed pigs (P<0.05). We observed decreased CD25 induction on T cells and monocytes (P<0.01) and decreased CTLA-4 induction (P<0.05) by the mitogen phytohemagglutinin on CD4 T cells from the probiotic group. Probiotic treatment also increased the proportion of CD4+ CD8+ T cells within the peripheral T-cell population and increased ileal IL-8 mRNA expression (P<0.05). In conclusion, superior ileal survival of L. salivarius compared with the other coadministered probiotics may be due to a competitive advantage conferred by its bacteriocin. The findings also suggest that the five-strain combination may function as a probiotic, at least in part, via immunomodulation.


Subject(s)
Bacteriocins/metabolism , Ileum/microbiology , Lactobacillus/growth & development , Lactobacillus/immunology , Probiotics , Animals , Antigens, CD/biosynthesis , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , CTLA-4 Antigen , Colony Count, Microbial , Enterobacteriaceae/isolation & purification , Feces/microbiology , Female , Interleukin-2 Receptor alpha Subunit/biosynthesis , Interleukin-8/biosynthesis , Intestinal Mucosa/microbiology , Lactobacillus/metabolism , Male , Monocytes/immunology , Swine
3.
Immunology ; 117(1): 1-10, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16423035

ABSTRACT

Natural killer (NK) cells were originally described as 'null' lymphocytes, but we have increasing evidence of their role in recognizing pathogen, and our knowledge of NK cell receptors continues to expand exponentially. Human NK cells have many receptors for human leucocyte antigen (HLA) class I. These killer immunoglobulin-like receptors (KIRs) and CD94/NKG2 receptors can signal in both positive and negative ways to regulate NK cell functions. The inhibitory receptors are the best characterized, but even in these cases much of their functional biology remains elusive. In this review, some recent advances in terms of the three-immunoglobulin (3Ig)-domain KIRs are discussed. Natural cytotoxicity receptors (NCRs) are among the activatory receptors found on NK cells. While pathogen ligands for these receptors have been described, endogenous ligands remain elusive. NCRs and NKG2D, a receptor for stress-induced antigens, appear to play complementary functional roles in terms of NK cell activation. More recently described on NK cells are the Toll-like receptors. In particular, these receptors of the innate immune system allow NK cells to directly sense pathogen, and their ligation on accessory cells indirectly activates NK cells through cytokine production. It is becoming clear that none of these receptor systems functions in isolation and that it is the sum of the signals (which will reflect the pathogenic situation), in addition to the cytokine milieu, that will direct NK cell activation. The resulting cytotoxicity, cytokine production and direct cell-cell regulatory interactions with other cells of the immune system, for example dendritic cells, ultimately determine the role of the NK cell in the context of an overall immune response.


Subject(s)
Killer Cells, Natural/immunology , Receptors, Immunologic/immunology , Cytotoxicity, Immunologic/immunology , Dendritic Cells/immunology , Histocompatibility Antigens Class I/immunology , Humans , Receptors, KIR , Toll-Like Receptors/immunology
4.
J Immunol ; 175(3): 1636-42, 2005 Aug 01.
Article in English | MEDLINE | ID: mdl-16034103

ABSTRACT

NK cells express receptors that allow them to recognize pathogens and activate effector functions such as cytotoxicity and cytokine production. Among these receptors are the recently identified TLRs that recognize conserved pathogen structures and initiate innate immune responses. We demonstrate that human NK cells express TLR3, TLR7, and TLR8 and that these receptors are functional. TLR3 is expressed at the cell surface where it functions as a receptor for polyinosinic acid:cytidylic acid (poly(I:C)) in a lysosomal-independent manner. TLR7/8 signaling is sensitive to chloroquine inhibition, indicating a requirement for lysosomal signaling as for other cell types. Both R848, an agonist of human TLR7 and TLR8, and poly(I:C) activate NK cell cytotoxicity against Daudi target cells. However, IFN-gamma production is differentially regulated by these TLR agonists. In contrast to poly(I:C), R848 stimulates significant IFN-gamma production by NK cells. This is accessory cell dependent and is inhibited by addition of a neutralizing anti-IL-12 Ab. Moreover, stimulation of purified monocyte populations with R848 results in IL-12 production, and reconstitution of purified NK cells with monocytes results in increased IFN-gamma production in response to R848. In addition, we demonstrate that while resting NK cells do not transduce signals directly in response to R848, they can be primed to do so by prior exposure to either IL-2 or IFN-alpha. Therefore, although NK cells can be directly activated by TLRs, accessory cells play an important and sometimes essential role in the activation of effector functions such as IFN-gamma production and cytotoxicity.


Subject(s)
Antigen-Presenting Cells/immunology , Interferon-gamma/biosynthesis , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Lymphocyte Activation/immunology , Membrane Glycoproteins/physiology , Receptors, Cell Surface/physiology , Cell Line , Cell Line, Tumor , Cells, Cultured , Humans , Imidazoles/pharmacology , Interleukin-12/physiology , Killer Cells, Natural/drug effects , Lymphocyte Activation/drug effects , Lysosomes/metabolism , Lysosomes/physiology , Membrane Glycoproteins/agonists , Membrane Glycoproteins/biosynthesis , Natural Cytotoxicity Triggering Receptor 1 , Natural Cytotoxicity Triggering Receptor 2 , Natural Cytotoxicity Triggering Receptor 3 , Poly I-C/pharmacology , Receptors, Cell Surface/agonists , Receptors, Cell Surface/biosynthesis , Receptors, Immunologic/biosynthesis , Receptors, Natural Killer Cell , Signal Transduction/immunology , Toll-Like Receptor 3 , Toll-Like Receptor 7 , Toll-Like Receptor 8 , Toll-Like Receptors
SELECTION OF CITATIONS
SEARCH DETAIL
...